(1-morpholinocyclohexyl)methanamine,
64269-03-0,
C-(1-Morpholin-4-yl-cyclohexyl)-methylamine,
[1-(Morpholin-4-Yl)Cyclohexyl]Methanamine,
(1-morpholin-4-ylcyclohexyl)methylamine,
Cyclohexanemethanamine,1-(4-morpholinyl)-,
1-[1-(morpholin-4-yl)cyclohexyl]methanamine,
F3284-8092,
(morpholin-4-ylcyclohexyl)methylamine,
BAS 08768013,
ACMC-209xyh,
AC1MKHX6,
AC1Q53QA,
AC1Q53QB,
SCHEMBL1700249,
CTK5C1019,
DTXSID10390141,
ALBB-000079,
ANW-48279,
BBL030339,
SBB010974,
STK500366,
ZINC19362023,
AKOS000201543,
MCULE-3579335401,
VS-0336,
(1-morpholin-4-ylcyclohexyl)methanamine,
1-(4-Morpholinyl)cyclohexanemethylamine,
NCGC00374321-01,
AJ-72883,
BR-48430,
1-(1-morpholin-4-ylcyclohexyl)methanamine,
DB-013721,
ST2402091,
TC-137024,
FT-0693172,
ST50285718,
W7602,
EN300-07970,
VU0608728-1,
A23524,
C67005,
Y-1646,
1-(1-Morpholin-4-ylcyclohexyl)methanamine, AldrichCPR,
C- -METHYLAMINE,
C11H22N2O,
(1-Morpholinocyclohexyl)methamine,
CID3157486,